Shu-Hsia Chen, Ph.D., is the Emily Herrmann endowed Professor in cancer immunotherapy, director of Cancer Immunotherapy Research Center and Immune Assessment Core at the Methodist Research Institute. Prior to joining Houston Methodist, she was a tenured Professor in the Department of Oncological Sciences and Surgery in the Icahn School of ...

Shu-Hsia Chen, PhD, is the Emily Herrmann endowed Professor in cancer immunotherapy, director of Cancer Immunotherapy Research Center and Immune Assessment Core at the Methodist Research Institute. Prior to joining Houston Methodist, she was a tenured Professor in the Department of Oncological Sciences and Surgery in the Icahn School of ...

He has been working on tumor metastasis and adaptive immune response since he joined Dr. Shu-hsia Chen’s lab at 2018. He also works for the ImmunoMonitoring core with duties of discussion with customers, sample preparation for staining (rare situations), Helios and Hyperion machine running trouble shoot, data transfer to bioinformatics, data ...

Learn more about Shu-Hsia Chen of the Mount Sinai Health System, such as current roles, education, and experience.

Dive into the research topics where Shu-Hsia Chen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Principal Investigator Shu-Hsia Chen, PhD Postdocs Hui-Ming Chen William Van der Touw Kyeongah Kang Dayanira, Alsina-beauchamp Students Sunny Mai Alice Yuan Shuo Wang Technician Fred Zhong Adminstrative Assistant Amanda Allen

Shu-Hsia Chen's 127 research works with 10,165 citations and 18,464 reads, including: LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR...

Care. Discover. Teach. With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and individualized clinical care, making groundbreaking biomedical …

Shu-Hsia CHEN of Icahn School of Medicine at Mount Sinai, New York (MSSM) | Contact Shu-Hsia CHEN